ICU-acquired Acute Kidney Treatment Market - Global Outlook and Forecast 2022-2028

February 2022 | 64 pages | ID: I8C72D5911EBEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of ICU-acquired Acute Kidney Treatment in Global, including the following market information:

Global ICU-acquired Acute Kidney Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global ICU-acquired Acute Kidney Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pre-renal Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of ICU-acquired Acute Kidney Treatment include Quark Pharmaceuticals, Fresenius Medical Care, B. Braun, Baxter international, Angion Biomedica Corp and Asahi Kasei Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ICU-acquired Acute Kidney Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global ICU-acquired Acute Kidney Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global ICU-acquired Acute Kidney Treatment Market Segment Percentages, by Type, 2021 (%)

• Pre-renal
• Intrinsic-renal
• Post-renal

Global ICU-acquired Acute Kidney Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global ICU-acquired Acute Kidney Treatment Market Segment Percentages, by Application, 2021 (%)

• Public Hospital
• Private Hospital

Global ICU-acquired Acute Kidney Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global ICU-acquired Acute Kidney Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies ICU-acquired Acute Kidney Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies ICU-acquired Acute Kidney Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Quark Pharmaceuticals
• Fresenius Medical Care
• B. Braun
• Baxter international
• Angion Biomedica Corp
• Asahi Kasei Medical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 ICU-acquired Acute Kidney Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global ICU-acquired Acute Kidney Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ICU-ACQUIRED ACUTE KIDNEY TREATMENT OVERALL MARKET SIZE

2.1 Global ICU-acquired Acute Kidney Treatment Market Size: 2021 VS 2028
2.2 Global ICU-acquired Acute Kidney Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top ICU-acquired Acute Kidney Treatment Players in Global Market
3.2 Top Global ICU-acquired Acute Kidney Treatment Companies Ranked by Revenue
3.3 Global ICU-acquired Acute Kidney Treatment Revenue by Companies
3.4 Top 3 and Top 5 ICU-acquired Acute Kidney Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies ICU-acquired Acute Kidney Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 ICU-acquired Acute Kidney Treatment Players in Global Market
  3.6.1 List of Global Tier 1 ICU-acquired Acute Kidney Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 ICU-acquired Acute Kidney Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global ICU-acquired Acute Kidney Treatment Market Size Markets, 2021 & 2028
  4.1.2 Pre-renal
  4.1.3 Intrinsic-renal
  4.1.4 Post-renal
4.2 By Type - Global ICU-acquired Acute Kidney Treatment Revenue & Forecasts
  4.2.1 By Type - Global ICU-acquired Acute Kidney Treatment Revenue, 2017-2022
  4.2.2 By Type - Global ICU-acquired Acute Kidney Treatment Revenue, 2023-2028
  4.2.3 By Type - Global ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global ICU-acquired Acute Kidney Treatment Market Size, 2021 & 2028
  5.1.2 Public Hospital
  5.1.3 Private Hospital
5.2 By Application - Global ICU-acquired Acute Kidney Treatment Revenue & Forecasts
  5.2.1 By Application - Global ICU-acquired Acute Kidney Treatment Revenue, 2017-2022
  5.2.2 By Application - Global ICU-acquired Acute Kidney Treatment Revenue, 2023-2028
  5.2.3 By Application - Global ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global ICU-acquired Acute Kidney Treatment Market Size, 2021 & 2028
6.2 By Region - Global ICU-acquired Acute Kidney Treatment Revenue & Forecasts
  6.2.1 By Region - Global ICU-acquired Acute Kidney Treatment Revenue, 2017-2022
  6.2.2 By Region - Global ICU-acquired Acute Kidney Treatment Revenue, 2023-2028
  6.2.3 By Region - Global ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America ICU-acquired Acute Kidney Treatment Revenue, 2017-2028
  6.3.2 US ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.3.3 Canada ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.3.4 Mexico ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe ICU-acquired Acute Kidney Treatment Revenue, 2017-2028
  6.4.2 Germany ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.4.3 France ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.4.4 U.K. ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.4.5 Italy ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.4.6 Russia ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.4.8 Benelux ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia ICU-acquired Acute Kidney Treatment Revenue, 2017-2028
  6.5.2 China ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.5.3 Japan ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.5.4 South Korea ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.5.6 India ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America ICU-acquired Acute Kidney Treatment Revenue, 2017-2028
  6.6.2 Brazil ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.6.3 Argentina ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa ICU-acquired Acute Kidney Treatment Revenue, 2017-2028
  6.7.2 Turkey ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.7.3 Israel ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia ICU-acquired Acute Kidney Treatment Market Size, 2017-2028
  6.7.5 UAE ICU-acquired Acute Kidney Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Quark Pharmaceuticals
  7.1.1 Quark Pharmaceuticals Corporate Summary
  7.1.2 Quark Pharmaceuticals Business Overview
  7.1.3 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Major Product Offerings
  7.1.4 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Revenue in Global Market (2017-2022)
  7.1.5 Quark Pharmaceuticals Key News
7.2 Fresenius Medical Care
  7.2.1 Fresenius Medical Care Corporate Summary
  7.2.2 Fresenius Medical Care Business Overview
  7.2.3 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Major Product Offerings
  7.2.4 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Revenue in Global Market (2017-2022)
  7.2.5 Fresenius Medical Care Key News
7.3 B. Braun
  7.3.1 B. Braun Corporate Summary
  7.3.2 B. Braun Business Overview
  7.3.3 B. Braun ICU-acquired Acute Kidney Treatment Major Product Offerings
  7.3.4 B. Braun ICU-acquired Acute Kidney Treatment Revenue in Global Market (2017-2022)
  7.3.5 B. Braun Key News
7.4 Baxter international
  7.4.1 Baxter international Corporate Summary
  7.4.2 Baxter international Business Overview
  7.4.3 Baxter international ICU-acquired Acute Kidney Treatment Major Product Offerings
  7.4.4 Baxter international ICU-acquired Acute Kidney Treatment Revenue in Global Market (2017-2022)
  7.4.5 Baxter international Key News
7.5 Angion Biomedica Corp
  7.5.1 Angion Biomedica Corp Corporate Summary
  7.5.2 Angion Biomedica Corp Business Overview
  7.5.3 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Major Product Offerings
  7.5.4 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Revenue in Global Market (2017-2022)
  7.5.5 Angion Biomedica Corp Key News
7.6 Asahi Kasei Medical
  7.6.1 Asahi Kasei Medical Corporate Summary
  7.6.2 Asahi Kasei Medical Business Overview
  7.6.3 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Major Product Offerings
  7.6.4 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Revenue in Global Market (2017-2022)
  7.6.5 Asahi Kasei Medical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. ICU-acquired Acute Kidney Treatment Market Opportunities & Trends in Global Market
Table 2. ICU-acquired Acute Kidney Treatment Market Drivers in Global Market
Table 3. ICU-acquired Acute Kidney Treatment Market Restraints in Global Market
Table 4. Key Players of ICU-acquired Acute Kidney Treatment in Global Market
Table 5. Top ICU-acquired Acute Kidney Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global ICU-acquired Acute Kidney Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global ICU-acquired Acute Kidney Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies ICU-acquired Acute Kidney Treatment Product Type
Table 9. List of Global Tier 1 ICU-acquired Acute Kidney Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ICU-acquired Acute Kidney Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - ICU-acquired Acute Kidney Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - ICU-acquired Acute Kidney Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - ICU-acquired Acute Kidney Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - ICU-acquired Acute Kidney Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Quark Pharmaceuticals Corporate Summary
Table 31. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Product Offerings
Table 32. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Fresenius Medical Care Corporate Summary
Table 34. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Product Offerings
Table 35. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), (2017-2022)
Table 36. B. Braun Corporate Summary
Table 37. B. Braun ICU-acquired Acute Kidney Treatment Product Offerings
Table 38. B. Braun ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Baxter international Corporate Summary
Table 40. Baxter international ICU-acquired Acute Kidney Treatment Product Offerings
Table 41. Baxter international ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Angion Biomedica Corp Corporate Summary
Table 43. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Product Offerings
Table 44. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Asahi Kasei Medical Corporate Summary
Table 46. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Product Offerings
Table 47. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. ICU-acquired Acute Kidney Treatment Segment by Type in 2021
Figure 2. ICU-acquired Acute Kidney Treatment Segment by Application in 2021
Figure 3. Global ICU-acquired Acute Kidney Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global ICU-acquired Acute Kidney Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global ICU-acquired Acute Kidney Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2021
Figure 8. By Type - Global ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 12. US ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 16. Germany ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 24. China ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa ICU-acquired Acute Kidney Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE ICU-acquired Acute Kidney Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. B. Braun ICU-acquired Acute Kidney Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Baxter international ICU-acquired Acute Kidney Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)